5-33445328-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_152295.5(TARS1):c.62G>A(p.Gly21Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,611,470 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_152295.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TARS1 | NM_152295.5 | c.62G>A | p.Gly21Asp | missense_variant | 2/19 | ENST00000265112.8 | NP_689508.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TARS1 | ENST00000265112.8 | c.62G>A | p.Gly21Asp | missense_variant | 2/19 | 1 | NM_152295.5 | ENSP00000265112.3 |
Frequencies
GnomAD3 genomes AF: 0.0104 AC: 1582AN: 152106Hom.: 27 Cov.: 32
GnomAD3 exomes AF: 0.00253 AC: 627AN: 247994Hom.: 10 AF XY: 0.00177 AC XY: 237AN XY: 134072
GnomAD4 exome AF: 0.000977 AC: 1425AN: 1459246Hom.: 23 Cov.: 30 AF XY: 0.000816 AC XY: 592AN XY: 725796
GnomAD4 genome AF: 0.0104 AC: 1584AN: 152224Hom.: 27 Cov.: 32 AF XY: 0.00994 AC XY: 740AN XY: 74444
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 18, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Trichothiodystrophy 7, nonphotosensitive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 17, 2022 | - - |
TARS1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at